OUR DREAM
As the lions and lionesses of the LIONHEALTH SB team, we want to build a market-leading health-tech company that develops products and solutions capable of addressing the specific needs of malnutrition for patients with various diseases by combining Science, Vegetable Extracts and ESG culture.
THE TEAM
The Founder
Paola (Elena) Lanati
- 11 years as a marketeer & executive in multinational companies: P&G, Astrazeneca, UCB, BMS and Amgen
- In 2010, she founded a group of companies that became leaders in consulting and services to the healthcare world, from which she exited in late 2021
- From 2022, she has been a business angel and investor in lifescience startups
- Vice President Italian Angels for Biotech (IAB)
- Included in Forbes Italy's 100 winning leaders
- Named among 50 Italian women in the international Inspiringfifty award
People
Our team consists of Lionesses and Lions who believe in the project and put their hearts and heads into making it happen, and is structured to follow the product development from formulation to market release in a 360-degree way. It consists of 4 macro-areas:
- R&D & Medical Affair
- Marketing & Brand Development
- Supply Chain & Operations Planning
- Sales & Market Access
The team consists of people with proven national and international experience in the field, but driven by the enthusiasm of youth.
Scientific Committee
Alessandro Armuzzi
Full Professor of Gastroenterology Humanitas University; Head UO Chronic Inflammatory Intestinal Diseases IRCCS Humanitas Research Hospital, Rozzano; President-elect ECCO
Riccardo Caccialanza
Director SC Dietetics and Clinical Nutrition Fondazione IRCCS Policlinico San Matteo
Antonio Gasbarrini
Full Professor of Internal Medicine, Catholic University of the Sacred Heart.
Director UOC Internal Medicine and Gastroenterology and CEMAD, Fondazione Policlinico Universitario A. Gemelli IRCCS
Salvo Leone
Director General AMICI Association Italy; President EFCCA
Maurizio Muscaritoli
Carmine Pinto
Medical Oncology Director, Comprehensive Cancer Centre, AUSL-IRCCS of Reggio Emilia
Former president AIOM (Italian Association of Medical Oncology)
research & pipeline
LIONHEALTH SB's Commitment to Disease Related Malnutritions.
LIONHEALTH SB has decided to focus its R&D efforts on developing products and solutions against Disease Related Malnutritions (DRM).
According to ESPEN, DRM are disease-related forms of malnutrition, resulting in weight and muscle mass loss, physical dysfunction, and leading to worse clinical outcomes. The prevalence of DRM varies between 20% and 80%, depending on the disease.
Our research focuses in these areas:
ONCOLOGY
RARE DISEASES
CENTRAL NERVOUS SYSTEM DISEASES
Both in vitro studies on human cell line models and clinical studies for scientific validation of products are underway, in collaboration with Italian universities and hospitals.
LIONHEALTH SB has spent in the 36% of investment in 2023 and 40% in 2024 in pure research and development activities.
ESG
LIONHEALTH, as a Benefit company, is committed to promoting ESG culture through the benefit plan.
The following are the main activities and related documents.
- Supply chain designed with attention to environmental sustainability.
- Measuring and neutralizing the Carbon Footprint
- Adoption of the Zero Emission Digital ( ZED) Protocol.
- Collaboration with Italian universities and hospitals
- Disbursement of the LIONHEALTH Award: scholarship intended for a University of Pavia undergraduate and Collegio Nuovo alumna with a thesis project dedicated to nutrition issues
- Made in Italy: Italian supply chain at all stages (research, prototyping, production, logistics, distribution)
- Membership in trade associations
Both LIONHEALTH Società Benefit's and LIONHEALTH Italia Società Benefit's governance documents are available here:
LIONHEALTH
LIONHEALTH ITALIA
AWARDS
America Innovation Award 2023
Italy USA Foundation
